The many downsides and one upside of India's clinical trials mess

  Hardly a week goes by when the term ˜clinical trial” is not in news, and unfortunately, in recent times, it’s been more for the wrong reasons. On January 9, Financial Times reported Novartis will face a criminal investigation for wrongful marketing practices of its popular blood pressure medicine Diovan. Then there was this detailed […]

The many downsides and one upside of India’s clinical trials mess

  Hardly a week goes by when the term ˜clinical trial” is not in news, and unfortunately, in recent times, it’s been more for the wrong reasons. On January 9, Financial Times reported Novartis will face a criminal investigation for wrongful marketing practices of its popular blood pressure medicine Diovan. Then there was this detailed […]

Don't be Averse to Clinical Trials, Fix the System

A panel report, as reported in Mint today, shows the much suspected irregularities in the drug controller’s office. This specific committee report is about the drug approval process, but I want to raise a related issue here, of clinical trials. I know, given the herd mentality, a fresh backlash against clinical trials will begin in […]

Don’t be Averse to Clinical Trials, Fix the System

A panel report, as reported in Mint today, shows the much suspected irregularities in the drug controller’s office. This specific committee report is about the drug approval process, but I want to raise a related issue here, of clinical trials. I know, given the herd mentality, a fresh backlash against clinical trials will begin in […]